Holdings of Virtus Biotech Clinical Trials Etf
ETFis Series Trust I · 124 declared positions · as of Apr 30, 2026
Original filing · Net assets 37.3M $ · Ten largest lines: 16.2 % of the equity sleeve
Sector breakdown
- Unattributed 100.0 %
Sector is not declared in Form N-PORT: this is a Titelia classification, decided company by company. The unattributed share is counted as such rather than spread over the others.
Currency breakdown
- USD 100.0 %
The currency each line is denominated in, as declared. It does not follow the country: a French company listed in the United States is declared in dollars.
Country breakdown
- US 86.3 %
- CA 3.7 %
- NL 3.1 %
- KY 2.4 %
- IE 2.0 %
- GB 1.6 %
- VG 0.6 %
- SG 0.3 %
Shares computed on the equity sleeve, the only part this site carries.
| Country | Lines | Value (USD) | Share |
|---|---|---|---|
| US | 106 | 32.2M $ | 86.34 % |
| CA | 4 | 1.4M $ | 3.72 % |
| NL | 4 | 1.2M $ | 3.08 % |
| KY | 3 | 901.6K $ | 2.42 % |
| IE | 2 | 729.4K $ | 1.96 % |
| GB | 3 | 580K $ | 1.55 % |
| VG | 1 | 229.6K $ | 0.62 % |
| SG | 1 | 117.7K $ | 0.32 % |
Positions
| Company | Shares | Value (USD) | Weight |
|---|---|---|---|
| Erasca Inc | 76,668 | 816.5K $ | 2.19 % |
| Enliven Therapeutics Inc | 16,370 | 674.9K $ | 1.81 % |
| Tango Therapeutics Inc | 29,518 | 638.2K $ | 1.71 % |
| Oruka Therapeutics Inc | 9,143 | 625.5K $ | 1.68 % |
| Spyre Therapeutics Inc | 8,208 | 611.1K $ | 1.64 % |
| Alumis Inc | 24,020 | 593.1K $ | 1.59 % |
| Dianthus Therapeutics Inc | 6,551 | 575.2K $ | 1.54 % |
| Kodiak Sciences Inc | 11,591 | 504K $ | 1.35 % |
| Revolution Medicines Inc | 3,496 | 503.8K $ | 1.35 % |
| Corvus Pharmaceuticals Inc | 32,976 | 500.9K $ | 1.34 % |
| Rezolute Inc | 153,338 | 490.7K $ | 1.31 % |
| Definium Therapeutics Inc | 21,993 | 481.2K $ | 1.29 % |
| CG oncology Inc | 6,741 | 449.9K $ | 1.21 % |
| JADE BIOSCIENCES INC | 18,425 | 449.6K $ | 1.20 % |
| Inhibrx Biosciences Inc | 3,467 | 448K $ | 1.20 % |
| Relay Therapeutics Inc | 34,371 | 445.4K $ | 1.19 % |
| GH RESEARCH PLC | 21,175 | 434.7K $ | 1.16 % |
| Nektar Therapeutics | 5,045 | 429K $ | 1.15 % |
| Tyra Biosciences Inc | 12,196 | 423.8K $ | 1.14 % |
| Vir Biotechnology Inc | 41,256 | 421.4K $ | 1.13 % |
| Intellia Therapeutics Inc | 30,599 | 412.5K $ | 1.10 % |
| CENTESSA PHARMACEUTICALS PLC | 10,411 | 410.4K $ | 1.10 % |
| AnaptysBio Inc | 6,139 | 403.5K $ | 1.08 % |
| Omeros Corp | 27,192 | 397K $ | 1.06 % |
| Tectonic Therapeutic Inc | 13,966 | 390.6K $ | 1.05 % |
| Allogene Therapeutics Inc | 182,788 | 389.3K $ | 1.04 % |
| Compass Pathways plc | 40,950 | 371K $ | 0.99 % |
| Edgewise Therapeutics Inc | 11,685 | 361.8K $ | 0.97 % |
| Palvella Therapeutics Inc | 2,798 | 359K $ | 0.96 % |
| Capricor Therapeutics Inc | 10,606 | 356.1K $ | 0.95 % |
| Vaxcyte Inc | 6,201 | 354.9K $ | 0.95 % |
| Pharvaris NV | 11,424 | 354.3K $ | 0.95 % |
| ArriVent Biopharma Inc | 11,300 | 351.3K $ | 0.94 % |
| Xenon Pharmaceuticals Inc | 6,264 | 351K $ | 0.94 % |
| Neurogene Inc | 13,193 | 344.2K $ | 0.92 % |
| Summit Therapeutics Inc | 15,708 | 337.1K $ | 0.90 % |
| Amylyx Pharmaceuticals Inc | 21,068 | 337.1K $ | 0.90 % |
| Celldex Therapeutics Inc | 10,032 | 329.9K $ | 0.88 % |
| Praxis Precision Medicines Inc | 1,026 | 327.1K $ | 0.88 % |
| Arcus Biosciences Inc | 12,819 | 326.9K $ | 0.88 % |
| Annexon Inc | 55,535 | 326K $ | 0.87 % |
| Terns Pharmaceuticals Inc | 6,132 | 324.6K $ | 0.87 % |
| Liquidia Corp | 8,268 | 324.2K $ | 0.87 % |
| Monte Rosa Therapeutics Inc | 16,922 | 324.1K $ | 0.87 % |
| Immunome Inc | 14,102 | 323.5K $ | 0.87 % |
| Bicara Therapeutics Inc | 14,934 | 322.3K $ | 0.86 % |
| Celcuity Inc | 2,621 | 318.1K $ | 0.85 % |
| Ironwood Pharmaceuticals Inc | 77,097 | 318K $ | 0.85 % |
| AbCellera Biologics Inc | 76,245 | 316.4K $ | 0.85 % |
| Precigen Inc | 74,799 | 311.2K $ | 0.83 % |
| Belite Bio Inc | 1,952 | 310.7K $ | 0.83 % |
| Beam Therapeutics Inc | 10,087 | 305.9K $ | 0.82 % |
| MoonLake Immunotherapeutics | 18,661 | 305.7K $ | 0.82 % |
| Taysha Gene Therapies Inc | 47,669 | 304.6K $ | 0.82 % |
| Cullinan Therapeutics Inc | 23,153 | 302.1K $ | 0.81 % |
| IMMATICS NV | 27,490 | 302.1K $ | 0.81 % |
| Rapport Therapeutics Inc | 9,118 | 302.1K $ | 0.81 % |
| Zymeworks Inc | 10,832 | 298.3K $ | 0.80 % |
| Apogee Therapeutics Inc | 3,580 | 296.7K $ | 0.79 % |
| Prothena Corp PLC | 26,642 | 294.7K $ | 0.79 % |
| ORIC Pharmaceuticals Inc | 29,424 | 290.7K $ | 0.78 % |
| Denali Therapeutics Inc | 15,351 | 287.4K $ | 0.77 % |
| Protagonist Therapeutics Inc | 2,894 | 286.4K $ | 0.77 % |
| MeiraGTx Holdings plc | 30,942 | 285.3K $ | 0.76 % |
| Immunovant Inc | 10,446 | 283.6K $ | 0.76 % |
| Rocket Pharmaceuticals Inc | 81,418 | 283.3K $ | 0.76 % |
| uniQure NV | 14,147 | 282.2K $ | 0.76 % |
| Soleno Therapeutics Inc | 5,306 | 280.3K $ | 0.75 % |
| MBX Biosciences Inc | 9,242 | 279.3K $ | 0.75 % |
| Stoke Therapeutics Inc | 8,521 | 278.8K $ | 0.75 % |
| Cytokinetics Inc | 4,355 | 278.6K $ | 0.75 % |
| CytomX Therapeutics Inc | 65,872 | 278K $ | 0.74 % |
| Scholar Rock Holding Corp | 5,888 | 274.4K $ | 0.74 % |
| AtaiBeckley Inc | 64,337 | 267.6K $ | 0.72 % |
| Nuvalent Inc | 2,633 | 264K $ | 0.71 % |
| Janux Therapeutics Inc | 18,038 | 259.2K $ | 0.69 % |
| Septerna Inc | 10,849 | 257.8K $ | 0.69 % |
| Dyne Therapeutics Inc | 14,322 | 251.4K $ | 0.67 % |
| Sionna Therapeutics Inc | 6,453 | 249.7K $ | 0.67 % |
| Kymera Therapeutics Inc | 3,077 | 249.5K $ | 0.67 % |
| Arbutus Biopharma Corp | 58,600 | 246.1K $ | 0.66 % |
| Nurix Therapeutics Inc | 14,473 | 241.7K $ | 0.65 % |
| Prime Medicine Inc | 67,319 | 238.6K $ | 0.64 % |
| ProKidney Corp | 124,892 | 237.3K $ | 0.64 % |
| ENGENE THERAPEUTICS INC | 32,625 | 237.2K $ | 0.64 % |
| Ideaya Biosciences Inc | 8,112 | 236.1K $ | 0.63 % |
| Xeris Biopharma Holdings Inc | 38,494 | 235.8K $ | 0.63 % |
| Cogent Biosciences Inc | 6,554 | 234.6K $ | 0.63 % |
| Viking Therapeutics Inc | 7,443 | 232.1K $ | 0.62 % |
| Biohaven Ltd | 23,938 | 229.6K $ | 0.61 % |
| EyePoint Inc | 17,260 | 227.8K $ | 0.61 % |
| 4D Molecular Therapeutics Inc | 25,461 | 225.8K $ | 0.60 % |
| Recursion Pharmaceuticals Inc | 63,742 | 220.5K $ | 0.59 % |
| Arvinas Inc | 21,940 | 217.2K $ | 0.58 % |
| Newamsterdam Pharma Co NV | 7,408 | 211.6K $ | 0.57 % |
| Savara Inc | 39,885 | 209K $ | 0.56 % |
| Assembly Biosciences Inc | 7,645 | 206K $ | 0.55 % |
| Xencor Inc | 16,707 | 199.3K $ | 0.53 % |
| Mineralys Therapeutics Inc | 7,478 | 199.3K $ | 0.53 % |
| Disc Medicine Inc | 3,004 | 198.1K $ | 0.53 % |
| Vera Therapeutics Inc | 5,541 | 197.3K $ | 0.53 % |
| Rigel Pharmaceuticals Inc | 6,766 | 195.5K $ | 0.52 % |
| Monopar Therapeutics Inc | 3,699 | 192.9K $ | 0.52 % |
| Maze Therapeutics Inc | 7,102 | 188.8K $ | 0.51 % |
| REGENXBIO Inc | 19,900 | 178.5K $ | 0.48 % |
| Sana Biotechnology Inc | 53,698 | 176.7K $ | 0.47 % |
| Bicycle Therapeutics PLC | 37,047 | 174.9K $ | 0.47 % |
| Structure Therapeutics Inc | 4,115 | 170.6K $ | 0.46 % |
| Invivyd Inc | 118,970 | 166.6K $ | 0.45 % |
| Lexeo Therapeutics Inc | 28,249 | 160.9K $ | 0.43 % |
| Verastem Inc | 28,720 | 156.8K $ | 0.42 % |
| Fulcrum Therapeutics Inc | 21,230 | 151.4K $ | 0.41 % |
| First Tracks Biotherapeutics Inc | 6,139 | 142.9K $ | 0.38 % |
| Keros Therapeutics Inc | 12,830 | 142.7K $ | 0.38 % |
| Altimmune Inc | 52,374 | 136.2K $ | 0.36 % |
| ZENAS BIOPHARMA INC | 6,799 | 131.4K $ | 0.35 % |
| Olema Pharmaceuticals Inc | 8,351 | 120.3K $ | 0.32 % |
| WaVe Life Sciences Ltd | 16,665 | 117.7K $ | 0.32 % |
| Viridian Therapeutics Inc | 8,542 | 115.1K $ | 0.31 % |
| Compass Therapeutics Inc | 53,489 | 94.7K $ | 0.25 % |
| Upstream Bio Inc | 10,169 | 93.4K $ | 0.25 % |
| Replimune Group Inc | 27,112 | 69.7K $ | 0.19 % |
| MEREO BIOPHARMA GROUP PLC | 127,193 | 34.1K $ | 0.09 % |
| Gossamer Bio Inc | 76,668 | 28.2K $ | 0.08 % |